A Phase 1 Pilot Study of the Subcutaneous (s.c.) Route to Facilitate the Administration of RRx-001

Trial Profile

A Phase 1 Pilot Study of the Subcutaneous (s.c.) Route to Facilitate the Administration of RRx-001

Discontinued
Phase of Trial: Phase I

Latest Information Update: 28 Jan 2016

At a glance

  • Drugs RRx 001 (Primary)
  • Indications Lymphoma; Solid tumours
  • Focus Adverse reactions
  • Sponsors EpicentRx
  • Most Recent Events

    • 20 Jan 2016 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
    • 03 Aug 2015 Planned End Date changed from 1 Apr 2015 to 1 Nov 2015 as reported by ClinicalTrials.gov.
    • 03 Aug 2015 Planned primary completion date changed from 1 Apr 2015 to 1 Oct 2015 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top